A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the virus from removing sugars on the cell surface.... Read more
In 2013, genetically engineered salmon will likely reach food shelves in supermarkets in the US. In a draft environmental assessment, at the fag end of December... Read more
In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and Mirae Biotech used non-viral vectors of nanoparticles... Read more
Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies... Read more
Pharma and medical devices companies face many grave challenges. Discovery & development is just the first one. Negotiating the complex regulatory field in various... Read more
India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brownfield foreign direct investment in pharma... Read more
Healthcare systems, globally, are grappling with different facets of the same problem: How to provide affordable healthcare to 100 percent of its citizens? Almost... Read more
The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 2009 slowdown, it was a single digit show in... Read more
The high tech manufacturing specialist industry in Taiwan is integrating its expertise in information technology with bioscience and healthcare. Just eight years... Read more
Taipei: Asia's largest medicare show opened in Taipei, Taiwan, with a crisp opening ceremony showcasing nine of the indigenously developed products selected from... Read more
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, this summer. In May, the CDSO came under fire... Read more
The fact that one-fifth of the world's TB patients are in India (according to WHO) acts as a good catalyst for companies to set up their production units. Also,... Read more
The Stop TB Partnership was established in 2000 to realize the goal of eliminating Tuberculosis (TB) as a public health problem and, ultimately, to obtain a world... Read more
China-based start-up company Shanghai BravoBio is dedicated to developing new types of human vaccines to fight against emerging infectious diseases and meet the... Read more
Real practical challenges persist in the development of stem cell therapies and chief among these are concerns for safety. Innovative technologies and processes... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
